Log In
BCIQ
Print this Print this
 

V212

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionInactivated varicella-zoster vaccine (VZV)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationVaricella zoster virus (VZV)
Indication DetailsPrevent varicella zoster virus (VZV) infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today